A detailed history of Planning Directions Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Planning Directions Inc holds 2,920 shares of NVO stock, worth $347,684. This represents 0.29% of its overall portfolio holdings.

Number of Shares
2,920
Previous 2,916 0.14%
Holding current value
$347,684
Previous $374,000 11.23%
% of portfolio
0.29%
Previous 0.27%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$122.71 - $146.91 $490 - $587
4 Added 0.14%
2,920 $416,000
Q1 2024

May 08, 2024

BUY
$102.11 - $135.92 $11,436 - $15,223
112 Added 3.99%
2,916 $374,000
Q3 2023

Oct 27, 2023

BUY
$90.94 - $199.54 $127,588 - $279,954
1,403 Added 100.14%
2,804 $255,000
Q2 2023

Jul 19, 2023

BUY
$155.98 - $172.65 $311 - $345
2 Added 0.14%
1,401 $227,000
Q1 2023

May 11, 2023

BUY
$132.34 - $159.14 $185,143 - $222,636
1,399 New
1,399 $223,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $269B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Planning Directions Inc Portfolio

Follow Planning Directions Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planning Directions Inc, based on Form 13F filings with the SEC.

News

Stay updated on Planning Directions Inc with notifications on news.